Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines to treat pain and other neuronal hyperexcitability disorders, to advance ...

Today 55 Years Ago: Legendary #Israeli spy, Eli Cohen, was publicly hanged in Damascus, #Syria. He sacrificed his life to keep Israel safe. Thank you Eli. Rest in Peace. #Israel pic.twitter.com ...

Eli Roth will write and direct 'Ice Cream Man,' a horror he says studios were too nervous to make and his 'most terrifying and insane’ film to date' ...

Eli Bohannan, a Walmart asset protection investigator, is running for Topeka City Council District 1. Bohannan's campaign priorities include addressing homelessness, infrastructure and education.

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year. The ...

Philadelphia Eagles cornerback Eli Ricks appeared to be lovestruck by Ivanka Trump as he and some teammates celebrated their Super Bowl win at the White House.

Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from HSBC to "reduce" from "buy," and a price-target cut to $700 from $1,150.

Eli Lilly appears to have had far more success, announcing promising Phase 3 trial results last week. The news caused the pharmaceutical's share price to surge — and the stock of Ozempic maker ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Eli Lilly sued four telehealth firms and their affiliates, but it is adopting a new legal strategy in its fight against compounded GLP-1s. Skip to Main Content. Manage alerts for this article; ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss. Latest U.S.